Jourdan Dunn to be the newest face for Maybelline New York
NEW YORK — Maybelline New York has tapped London-bred beauty Jourdan Dunn as its newest spokesmodel.
Dunn will make her Maybelline New York debut in print and television advertising campaigns in April.
"Jourdan’s look, style and positive energy are perfect for the Maybelline New York brand," said Jerome Bruhat, global brand president of Maybelline New York. "She truly reflects Maybelline’s vision of global beauty."
Dunn was first discovered by a model scout while out with friends. She was signed soon after and made her runway debut during the 2007 Fall New York Fashion Week. As a featured model in British Vogue, labeled as a "new star" and named "Top 10 Newcomer" by style.com later that same year, she was on the road to success very early in her career.
She has since lit up the runways for Prada, Christian Dior, Chanel, Alexander McQueen, Oscar de la Renta, Miu Miu, Balenciaga, Calvin Klein, Ralph Lauren, Louis Vuitton, Tom Ford, Marc Jacobs, Alexander Wang, Burberry, Lanvin, Hermes, Givenchy, Valentino, Jean-Paul Gaultier and Balmain to name a few. She has appeared in the American, British, Paris, Italian, Japanese and Russian editions of Vogue. She has graced the pages of fashion magazines W, Numero, Allure, i-D, V, POP, and Dazed & Confused. She has been a part of various campaigns for ck Calvin Klein, CK1 fragrance, Yves Saint Laurent, Burberry, Burberry Beauty, Gap, DKNY, H&M, Express, Aldo, Banana Republic, Tommy Hilfiger, Rag & Bone, Topshop, John Galliano and Benetton, among others.
When she is not modeling, Dunn is a mother to her son Riley who was diagnosed with sickle cell anemia. This has led to her active involvement as the Parent Ambassador for the Sickle Cell Disease Association of America. In addition to being a mother and philanthropist, Dunn is a self-taught cook. She hosts a lifestyle and cooking program titled "Well Dunn with Jourdan Dunn." The show is available through Jay Z’s YouTube channel, Life+Times, and features a different celebrity guest each episode.
Garnier Haircolor names actress Blanca Soto as newest ambassador
NEW YORK — Garnier Haircolor has named actress and former model Blanca Soto as its newest spokeswoman.
A former top model, Soto is an actress from Mexico who is known for her roles in "Eva Luna," "El Talisman" and "Porque el amor manda." Winner of the New York International Independent Film and Video Festival’s "Best Actress Award in a Short Film," she has been featured in more than 100 top international magazines, including Maxim as one of the "Top Sexiest Women."
Soto will be featured in print and TV ads for the Garnier Nutrisse Ultra Color Series. The Ultra Color Series includes shades that are specifically created for dark hair by using color-boosting technologies that offer dramatic lift and visibly reflective color results in one step. Because nourished hair creates the best-looking color, Ultra Lift features Garnier’s three signature Nutritive Fruit Oils — avocado, olive and shea — to nourish hair.
Ultra Color’s creamy texture offers easy application that lifts up to four levels for maximum benefits and comes in shade ranges that include Ultra Color Series for dark hair, Ultra Reflective Blacks, Ultra Lightening Browns, Ultra Lightening Blondes and Ultra Intense Reds.
"I am thrilled that Blanca is joining the Garnier roster of amazing spokespersons. She represents the vibrant, intense beauty that the Ultra Color series stands for perfectly," said Daniel Villarroel, assistant VP, Garnier integrated marketing.
Blanca will appear in ads beginning in April, and her first signature Nutrisse Ultra Color hue is Light Golden Brown.
Garnier Nutrisse Ultra Color Series can be found at mass-market retailers nationwide at a suggested retail price of $7.99.
CDC: Diabetes may be on the rise, but complications are on the decline
ATLANTA — Rates of five major diabetes-related complications have declined substantially in the last 20 years among U.S. adults with diabetes, according to a study by the Centers for Disease Control and Prevention, published in the current issue of the New England Journal of Medicine.
Rates of lower-limb amputation, end-stage kidney failure, heart attack, stroke and deaths due to high blood sugar (hyperglycemia) all declined. Cardiovascular complications and deaths from high blood sugar decreased by more than 60% each, while the rates of both strokes and lower extremity amputations — including upper and lower legs, ankles, feet and toes — declined by about half. Rates for end stage kidney failure fell by about 30%.
“These findings show that we have come a long way in preventing complications and improving quality of life for people with diabetes,” said Edward Gregg, a senior epidemiologist in CDC’s Division of Diabetes Translation and lead author of the study. “While the declines in complications are good news, they are still high and will stay with us unless we can make substantial progress in preventing Type 2 diabetes.”
Because the number of adults reporting diabetes during this time frame more than tripled — from 6.5 million to 20.7 million — these major diabetes complications continue to put a heavy burden on the U.S. healthcare system. Nearly 26 million Americans have diabetes, and an additional 79 million have prediabetes and are at risk of developing the disease. Diabetes and its complications account for $176 billion in total medical costs each year.
CDC researchers used data from the National Health Interview Survey, National Hospital Discharge Survey, U.S. Renal Data System and Vital Statistics to examine trends in the occurrence of diabetes-related complications in the United States between 1990 and 2010.
Although all complications declined, the greatest declines in diabetes-related complications occurred for heart attack and stroke, particularly among people ages 75 years and older. The study authors attribute the declines in diabetes-related complications to increased availability of healthcare services, risk factor control and increases in awareness of the potential complications of diabetes.